APA

Roy S., Narang B. K., Rastogi S. K. & Rawal R. K. (20150812). A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib. : Anti-cancer agents in medicinal chemistry.

Chicago

Roy Subhajit, Narang Bawneet K, Rastogi Shiva K and Rawal Ravindra K. 20150812. A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib. : Anti-cancer agents in medicinal chemistry.

Harvard

Roy S., Narang B. K., Rastogi S. K. and Rawal R. K. (20150812). A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib. : Anti-cancer agents in medicinal chemistry.

MLA

Roy Subhajit, Narang Bawneet K, Rastogi Shiva K and Rawal Ravindra K. A novel multiple tyrosine-kinase targeted agent to explore the future perspectives of anti-angiogenic therapy for the treatment of multiple solid tumors: cabozantinib. : Anti-cancer agents in medicinal chemistry. 20150812.